Brought to you by 
Akorn pays $591mm to buy Hi-Tech Pharmacal
27 Aug 2020
Executive Summary
Niche drug company Akorn Inc. has acquired public branded, generic, and OTC firm Hi-Tech Pharmacal Co. Inc., for $43.50 per share (a 23% premium), for a total of $591mm in cash.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Nutraceuticals
- OTC, Consumer
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Akorn pays $591mm to buy Hi-Tech Pharmacal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice